Zions Bancorporation’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$912 Sell
36
-23
-39% -$583 ﹤0.01% 822
2024
Q3
$1.47K Sell
59
-15,482
-100% -$458K ﹤0.01% 808
2024
Q2
$461K Buy
15,541
+2,392
+18% +$66.4K 0.04% 247
2024
Q1
$396K Buy
13,149
+13,109
+32,773% +$364K 0.03% 271
2023
Q4
$1.14K Hold
40
﹤0.01% 848
2023
Q3
$1.48K Hold
40
﹤0.01% 834
2023
Q2
$1.56K Hold
40
﹤0.01% 839
2023
Q1
$1.46K Sell
40
-301
-88% -$9.5K ﹤0.01% 840
2022
Q4
$10.5K Buy
+341
New +$10.6K ﹤0.01% 704

Other funds holding RTO

Zions Bancorporation's RTO Position: Q4 2024 in Review

Zions Bancorporation reduced its Rentokil (RTO) stake by 39% in Q4 2024, selling an estimated $583 and leaving 36 shares worth $912. The position accounts for ﹤0.01% of the portfolio, ranked #822.

Zions Bancorporation first reported a position in RTO in Q4 2022 and has held it in 9 quarters since. The position peaked at $461K in Q2 2024. 227 funds tracked by Wall St. Rank hold RTO as of Q4 2024.

  • Zions Bancorporation held 36 shares of Rentokil worth $912 as of Q4 2024.
  • Zions Bancorporation sold 23 Rentokil shares in Q4 2024, an estimated $583.
  • Rentokil made up ﹤0.01% of Zions Bancorporation's portfolio in Q4 2024, its #822 holding.
  • Zions Bancorporation first reported a position in Rentokil in Q4 2022 and has held it in 9 quarters since.
  • Zions Bancorporation's Rentokil position peaked at $461K in Q2 2024.
  • 227 funds tracked by Wall St. Rank held Rentokil as of Q4 2024.

Based on Zions Bancorporation's 13F filing for Q4 2024, filed 11 Feb 2025.